Mediterranean diet vs. Western diet for fatigue in AIH
Part of Digestive system, Immune system & allergy clinical trials.
This study tests whether a Mediterranean diet can reduce fatigue in people with autoimmune hepatitis (AIH) compared to a typical Western diet. You will receive frozen meals for a week and track your energy levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have autoimmune hepatitis (AIH) diagnosed more than 6 months ago, confirmed by a liver biopsy or a specific scoring system.
- Your AIH medicines must be stable (no changes in the last 4 weeks).
- You must have fatigue that is worse than average (a score of 55 or higher on a fatigue survey).
- You cannot have celiac disease, advanced liver scarring, or other serious liver conditions.
- You must be able to store and prepare frozen meals delivered weekly, and be willing to follow a Mediterranean or Western diet for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at fats (lipids) in the blood of people with autoimmune hepatitis to find patterns that might help diagnose or monitor the disease. It may lead to better ways to manage the condition.
This study looks at what factors affect how well the liver responds to treatment in people with autoimmune hepatitis. It may help doctors understand why some people respond better than others and could lead to more personalized care.
This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.
This study compares two medicines, azathioprine and mycophenolate mofetil, to see which works better for treating autoimmune hepatitis. If you haven't been treated before, this trial could help find a more effective way to manage your condition.
This study is building a database and collection of samples from people with autoimmune hepatitis in Italy. It aims to learn more about the disease and improve care.
This study tests a new biologic medicine called inebilizumab that may help people whose autoimmune hepatitis hasn't improved with standard treatments. The goal is to see if it can reduce liver inflammation and improve their condition.
Hear when a new Autoimmune Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.